This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Monsanto Will Profit Most From Bed Bug Epidemic, Poll Says


NEW YORK (TheStreet) -- According to readers of TheStreet, the company most likely to benefit from the bed-bug epidemic is agricultural seed giant Monsanto (MON) -- which also happens to be one the biggest names in the business of manufacturing pest control products.

While Monsanto garnered 21.7% of the votes in our poll on which stock is best poised to profit from the bed-bug outbreak, Sealy (ZZ) came in a close second, receiving 20.4% of the votes cast. Clorox (CLX) came in third, with 15.3% of the votes.

E.I. du Pont de Nemours (DD) picked up 14% of the votes, while Procter & Gamble (PG) received 12.1%. Rollins (ROL), Ecolab (ECL) and Bayer AG (BAYRY) logged 7.6%, 5.1% and 3.8% respectively.

According to brand and communications company Hall & Partners, its WebWord tool -- which the company uses to monitor online "buzz" for clients and brands it's tracking -- shows that "fail" and "resistant" are among the words most strongly associated with searches on "bed bugs and cure." However, no brand is being singled as a failure. Likewise, no search results were showing up for "cure."

Hall & Partners believes these results indicate an important opportunity for many consumer goods companies. "While people are talking a lot about bed bugs lately, no one seems to know what to do with them," Hall & Partners director Brigette Lytle said.

"If a brand started talking about how they are a cure for bed bugs, they can have a stronghold in the market before anyone else gets out there with it."

According to reports, the bed-bug outbreak has reached record levels across the U.S., with Google's (GOOG) New York City office being among the latest to fall victim to the critters.

-- Written by Andrea Tse in New York.



>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to Andrea Tse.

>To submit a news tip, send an email to: tips@thestreet.com.

RELATED STORIES:


Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs